The perils of gene patents

S. L. Salzberg

doi:10.1038/clpt.2012.6

The perils of gene patents

S. L. Salzberg

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.

Original language	English (US)
Pages (from-to)	969-971
Number of pages	3
Journal	Clinical pharmacology and therapeutics
Volume	91
Issue number	6
DOIs	https://doi.org/10.1038/clpt.2012.6
State	Published - Jun 2012

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1038/clpt.2012.6

Fingerprint Dive into the research topics of 'The perils of gene patents'. Together they form a unique fingerprint.

Cite this

@article{b2ec536a3ba64d7f9231de963c8ec6e6,

title = "The perils of gene patents",

abstract = "I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.",

author = "Salzberg, {S. L.}",

year = "2012",

month = jun,

doi = "10.1038/clpt.2012.6",

language = "English (US)",

volume = "91",

pages = "969--971",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - The perils of gene patents

AU - Salzberg, S. L.

PY - 2012/6

Y1 - 2012/6

N2 - I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.

AB - I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.

UR - http://www.scopus.com/inward/record.url?scp=84861401540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861401540&partnerID=8YFLogxK

U2 - 10.1038/clpt.2012.6

DO - 10.1038/clpt.2012.6

M3 - Review article

C2 - 22609909

AN - SCOPUS:84861401540

VL - 91

SP - 969

EP - 971

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 6

ER -